COVID and structural cartelisation: market-state-society ties and the political economy of Pharma

Overview of attention for article published in New Political Economy, January 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 644)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 3 news outlets
twitter: 137 X users

wikipedia: 1 Wikipedia page

Readers on

mendeley: 4 Mendeley

Summary News X Wikipedia

So far, Altmetric has seen 3 news stories from 3 outlets.

Should Big Pharma pay poor countries for finding new diseases?

Vox.com, 28 Feb 2024

The Covid-19 pandemic revealed that, in a global health emergency, all the aspirational rhetoric about international…

Les leçons de la COVID révèlent l’évolution du pouvoir de monopole dans l’industrie biopharmaceutique

Nouvelles du monde, 18 Feb 2024

Tout au long de la pandémie de coronavirus, le professeur de politique Matt Sparke, codirecteur du programme de santé mondiale…

Lessons from COVID reveal how monopoly power in the biopharmaceutical industry is evolving

UCSC News, 17 Feb 2024

Throughout the coronavirus pandemic, Politics Professor Matt Sparke, co-director of UC Santa Cruz’s Global and Community Health…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.